Vyas Tungaturti is a seasoned M&A operator and advisor specializing in large-scale mergers, acquisitions, and private equity due diligence. His experience spans integration and divestiture office leadership, complex cross-border transactions, and the application of AI and machine learning to deal execution. Founder of CorpDev.Org and builder of Kai, an AI due-diligence platform for deal teams, Vyas writes on deal intelligence, value creation, and how AI is reshaping M&A and PE workflows.
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand The European Union's antitrust regulators are poised to deliver a landmark decision by June 25 on Mars' proposed $36 billion...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand Special Purpose Acquisition Companies (SPACs) have staged a remarkable resurgence in 2025, fueled by regulatory shifts under the...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand In a landmark transaction reshaping North America's energy landscape, Vistra Corp (NYSE: VST) has positioned itself as the...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand In a dramatic escalation of its two-year pursuit of Pittsburgh-based U.S. Steel, Japan's Nippon Steel has unveiled a $14 billion...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand Deal Snapshot: 23andMe Acquisition AcquirerRegeneron Pharmaceuticals Target23andMe (excl. Lemonaid Health) Price$256M (92% below...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand BT Group stands on the precipice of exiting the premium sports broadcasting arena after 12 years, with advanced negotiations...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand In a landmark corporate-regulatory alignment, Verizon Communications secured Federal Communications Commission approval for its...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand French nuclear giant Orano's potential divestment from Niger marks a pivotal shift in global uranium markets and European energy...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand In a dual strategic move reshaping the digital health landscape, London-based healthtech unicorn Huma Therapeutics has acquired...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand In a bold restructuring move emblematic of private equity's value-crystallization strategies, Adevinta ASA – the Oslo-based...
